期刊文献+

卵巢癌耐药机制的研究进展 被引量:9

下载PDF
导出
摘要 卵巢恶性肿瘤是妇科三大恶性肿瘤之一,仅次于宫颈癌,宫体癌,居第三位〔1〕。卵巢癌的治疗主要是以手术为主的综合治疗,但化疗已经起到举足轻重的作用。在临床中很多肿瘤的初次化疗一般可以取得较好的效果,然而最终仍难免复发,其中卵巢癌也是如此〔2〕。随着化疗的进行,卵巢癌细胞逐渐产生耐药(MDR)。卵巢癌术后治疗的失败,在很大程度上是由于卵巢癌细胞对化疗药物产生了MDR。
出处 《中国老年学杂志》 CAS CSCD 北大核心 2015年第4期1117-1120,共4页 Chinese Journal of Gerontology
基金 江西省教育厅科技项目(No.GJJ12543) 江西省卫生厅科技项目(No.20123181)
  • 相关文献

参考文献35

  • 1Jacqueline V. Chapman,Valérie Gouazé-Andersson,Ramin Karimi,Maria C. Messner,Myles C. Cabot.P-glycoprotein antagonists confer synergistic sensitivity to short-chain ceramide in human multidrug-resistant cancer cells[J]. Experimental Cell Research . 2011 (12) 被引量:1
  • 2黄明钜.叶酸结合蛋白与卵巢癌多药耐药关系的研究[D].广西医科大学2012 被引量:1
  • 3Dong-Jun Peng,Juan Wang,Jun-Ying Zhou,Gen Sheng Wu.Role of the Akt/mTOR survival pathway in cisplatin resistance in ovarian cancer cells[J]. Biochemical and Biophysical Research Communications . 2010 (3) 被引量:1
  • 4Lu, D,Shi, H-C,Wang, Z-X,Gu, X-W,Zeng, Y J.Multidrug resistance-associated biomarkers PGP, GST-[pi], Topo-II and LRP as prognostic factors in primary ovarian carcinoma[J]. British Journal of Biomedical Science . 2011 (2) 被引量:1
  • 5Feng Gu,Yongjie Ma,Zuping Zhang,Jinghui Zhao,Hisayuki Kobayashi,Lun Zhang,Li Fu.Expression of Stat3 and Notch1 is associated with cisplatin resistancein head and neck squamous cell carcinoma[J]. Oncology Reports . 2010 (3) 被引量:1
  • 6Keren Wang,Yuqin Ye,Zheli Xu,Xuan Zhang,Zhifu Hou,Youbin Cui,Yan Song.Interaction between BRCA1/BRCA2 and ATM/ATR associate with breast cancer susceptibility in a Chinese Han population[J]. Cancer Genetics and Cytogenetics . 2010 (1) 被引量:1
  • 7Dabholkar M,Bostick-Bruton F,Weber C,Bohr V A,Egwuagu C,Reed E.ERCC1 and ERCC2 expression in malignant tissues from ovarian cancer patients. Journal of the National Cancer Institute . 1992 被引量:1
  • 8Li Qing-Quan,Xu Jing-Da,Wang Wen-Juan,Cao Xi-Xi,Chen Qi,Tang Feng,Chen Zhong-Qing,Liu Xiu-Ping,Xu Zu-De.Twist1-mediated adriamycin-induced epithelial-mesenchymal transition relates to multidrug resistance and invasive potential in breast cancer cells. Clinical cancer research : an official journal of the American Association for Cancer Research . 2009 被引量:1
  • 9王宁.卵巢癌TGFBI启动子甲基化与卵巢癌耐药的相关性研究[D].山东大学2012 被引量:1
  • 10李状.二氢叶酸还原酶与卵巢上皮癌多药耐药关系的研究[D].广西医科大学2012 被引量:1

二级参考文献398

共引文献149

同被引文献97

  • 1凌云华,葛勇前,陆国椿.肿瘤体外药敏试验及其与临床用药之间的关系[J].中国癌症杂志,2004,14(6):567-569. 被引量:10
  • 2张咏梅,王朝卿,孙建锁,宋光耀.非小细胞肺癌组织中MRP1 mRNA和GST-π mRNA的表达及意义[J].中华肿瘤防治杂志,2007,14(12):913-916. 被引量:9
  • 3张雯碧,鹿欣.卵巢癌化疗耐药相关基因与预后的研究进展[J].国外医学(妇产科学分册),2007,34(3):193-196. 被引量:16
  • 4曹泽毅.妇科常见肿瘤诊治指南[M].3版.北京:人民卫生出版社,2004:72-93. 被引量:2
  • 5Parente-Pereira AC,Shmeeda H,Whilding LM,et al.Adoptive immunotherapy of epithelial ovarian cancer with Vγ9Vδ2Tcells,potentiated by liposomal alendronic acid[J].J Immunol,2014,193(11):5557-5566. 被引量:1
  • 6Bouet-Toussaint F,Cabillic F,Toutirais O,et al.Vgamma9Vdelta 2Tcell-mediated recognition of human solid tumors.Potential for immunotherapy of hepatocellular and colorectal carcinomas[J].Cancer Immunol Immunother,2008,57(4):531-539. 被引量:1
  • 7Wu KN,Wang YJ,He Y,et al.Dasatinib promotes the potential of proliferation and antitumor responses of humanγδT cells in a long-term induction ex vivo environment[J].Leukemia,2014,28(1):206-210. 被引量:1
  • 8Sun S,Zheng K,Zhao H,et al.Regulatory Effect of Astragalus Polysaccharides on intestinal ntraepithelialγδT cells of tumor bearing mice[J].Molecules,2014,19(9):15224-15236. 被引量:1
  • 9Sun S,Zheng K,Zhao H,et al.Regulatory effect of astragalus polysaccharides on intestinal intraepithelialγδT cells of tumor bearing mice[J].Molecules,2014,19(9):15224-15236. 被引量:1
  • 10Ismail AS,Severson KM,Vaishnava S,et al.Gammadelta intraepithelial lymphocytes are essential mediators of hostmicrobial homeostasis at the intestinal mucosal surface[J].Proc Natl Acad Sci USA,2011,108(21):8743-8748. 被引量:1

引证文献9

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部